TXMD Press Releases

TherapeuticsMD Completes Enrollment in The Rejoice Trial, a Phase 3 Clinical Trial of TX-004HR (estradiol in VagiCap™)
9 June 2015

TherapeuticsMD, Inc. to participate in upcoming investor conferences
26 May 2015

TherapeuticsMD featured at the 10th European Congress on Menopause and Andropause
21 May 2015

Click here for all press releases
Investor Information
Click here to become a more informed investor and learn more about investing in TXMD.
<
Industry News